Currently, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) markers are widely used in routine clinical practice for breast cancer classification and therapeutic guidance[22]. This evidence concerns the gene ERBB2 and breast carcinoma.